129 related articles for article (PubMed ID: 29734108)
1. Quantum dots-based sandwich immunoassay for sensitive detection of Alzheimer's disease-related Aβ
Tang M; Pi J; Long Y; Huang N; Cheng Y; Zheng H
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Aug; 201():82-87. PubMed ID: 29734108
[TBL] [Abstract][Full Text] [Related]
2. A sandwich immunoassay for detection of Aβ(1-42) based on quantum dots.
Pi J; Long Y; Huang N; Cheng Y; Zheng H
Talanta; 2016; 146():10-5. PubMed ID: 26695227
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model.
Borghys H; Jacobs T; Van Broeck B; Dillen L; Dhuyvetter D; Gijsen H; Mercken M
J Alzheimers Dis; 2014; 38(1):39-48. PubMed ID: 23948925
[TBL] [Abstract][Full Text] [Related]
4. Transition metal-coordinated graphitic carbon nitride dots as a sensitive and facile fluorescent probe for β-amyloid peptide detection.
Zhang Y; Meng S; Ding J; Peng Q; Yu Y
Analyst; 2019 Jan; 144(2):504-511. PubMed ID: 30474660
[TBL] [Abstract][Full Text] [Related]
5. Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots.
Xia N; Zhou B; Huang N; Jiang M; Zhang J; Liu L
Biosens Bioelectron; 2016 Nov; 85():625-632. PubMed ID: 27240009
[TBL] [Abstract][Full Text] [Related]
6. Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease.
Thijssen EH; Verberk IMW; Vanbrabant J; Koelewijn A; Heijst H; Scheltens P; van der Flier W; Vanderstichele H; Stoops E; Teunissen CE
Sci Rep; 2021 May; 11(1):9736. PubMed ID: 33958661
[TBL] [Abstract][Full Text] [Related]
7. An UHPLC-MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction.
Lin PP; Chen WL; Yuan F; Sheng L; Wu YJ; Zhang WW; Li GQ; Xu HR; Li XN
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():82-91. PubMed ID: 29102244
[TBL] [Abstract][Full Text] [Related]
8. Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab.
Lachno DR; Evert BA; Vanderstichele H; Robertson M; Demattos RB; Konrad RJ; Talbot JA; Racke MM; Dean RA
J Alzheimers Dis; 2013; 34(4):897-910. PubMed ID: 23302661
[TBL] [Abstract][Full Text] [Related]
9. Competitive electrochemical immunoassay for detection of β-amyloid (1-42) and total β-amyloid peptides using p-aminophenol redox cycling.
Liu L; He Q; Zhao F; Xia N; Liu H; Li S; Liu R; Zhang H
Biosens Bioelectron; 2014 Jan; 51():208-12. PubMed ID: 23962708
[TBL] [Abstract][Full Text] [Related]
10. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
[TBL] [Abstract][Full Text] [Related]
11. The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease.
Pannee J; Törnqvist U; Westerlund A; Ingelsson M; Lannfelt L; Brinkmalm G; Persson R; Gobom J; Svensson J; Johansson P; Zetterberg H; Blennow K; Portelius E
Neurosci Lett; 2014 Jun; 573():7-12. PubMed ID: 24796810
[TBL] [Abstract][Full Text] [Related]
12. A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.
Song L; Lachno DR; Hanlon D; Shepro A; Jeromin A; Gemani D; Talbot JA; Racke MM; Dage JL; Dean RA
Alzheimers Res Ther; 2016 Dec; 8(1):58. PubMed ID: 27978855
[TBL] [Abstract][Full Text] [Related]
13. Competitive fluorescent immunoassay for the ultrasensitive determination of amyloid beta peptide1-42 based on Ag@SiO
Yu Q; Zheng M; Li M; Jiang R; Zhu H; Guo H; Sun H; Liu M
Mikrochim Acta; 2023 Apr; 190(5):194. PubMed ID: 37103596
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of human Enterovirus 71 and Coxsackievirus B3 by dual-color quantum dots and homogeneous immunoassay.
Chen L; Zhang X; Zhou G; Xiang X; Ji X; Zheng Z; He Z; Wang H
Anal Chem; 2012 Apr; 84(7):3200-7. PubMed ID: 22390751
[TBL] [Abstract][Full Text] [Related]
15. Determination of 17beta-oestradiol by fluorescence immunoassay with streptavidin-conjugated quantum dots as label.
Sun M; Du L; Gao S; Bao Y; Wang S
Steroids; 2010 Jun; 75(6):400-3. PubMed ID: 20152848
[TBL] [Abstract][Full Text] [Related]
16. Development of an Immunoassay for the Detection of Amyloid Beta 1-42 and Its Application in Urine Samples.
Wongta A; Hongsibsong S; Chantara S; Pattarawarapan M; Sapbamrer R; Sringarm K; Xu ZL; Wang H
J Immunol Res; 2020; 2020():8821181. PubMed ID: 33426095
[TBL] [Abstract][Full Text] [Related]
17. Development and Technical Validation of an Immunoassay for the Detection of APP
Klafki HW; Rieper P; Matzen A; Zampar S; Wirths O; Vogelgsang J; Osterloh D; Rohdenburg L; Oberstein TJ; Jahn O; Beyer I; Lachmann I; Knölker HJ; Wiltfang J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911706
[TBL] [Abstract][Full Text] [Related]
18. Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.
Pérez-Grijalba V; Fandos N; Canudas J; Insua D; Casabona D; Lacosta AM; Montañés M; Pesini P; Sarasa M
J Alzheimers Dis; 2016 Sep; 54(2):751-62. PubMed ID: 27567833
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders.
Nutu M; Zetterberg H; Londos E; Minthon L; Nägga K; Blennow K; Hansson O; Ohrfelt A
Dement Geriatr Cogn Disord; 2013; 36(1-2):99-110. PubMed ID: 23860354
[TBL] [Abstract][Full Text] [Related]
20. SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer's Disease Biomarkers.
Yu D; Yin Q; Wang J; Yang J; Chen Z; Gao Z; Huang Q; Li S
Int J Nanomedicine; 2021; 16():1901-1911. PubMed ID: 33707945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
